Active Ingredient: Clesrovimab
Clesrovimab is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season.
Clesrovimab should be used in accordance with official recommendations.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Intramuscular, 105 milligrams clesrovimab, one dose.
The recommended dose is 105 mg administered as a single 0.7 mL intramuscular (IM) injection.
For neonates and infants born during the RSV season, clesrovimab should be administered starting from birth. For infants born outside the RSV season, it should be administered once prior to the start of their first RSV season.
Dosing in infants with a body weight between 0.5 kg and 1.1 kg is based on extrapolation; no clinical data are available. Exposure in infants <1.1 kg is anticipated to yield higher exposures than in those weighing more. The benefits and risks of clesrovimab in infants <1.1 kg should be carefully considered.
There are limited clinical data available in extremely preterm infants (gestational age (GA) <29 weeks) who are of chronological age less than 8 weeks. No clinical data are available in infants with a postmenstrual age (GA plus chronological age) of less than 32 weeks.
For infants undergoing cardiac surgery with cardiopulmonary bypass during the RSV season, an additional 105 mg dose is recommended as soon as the infant is stable after surgery to ensure adequate clesrovimab serum levels.
Clesrovimab injection should be administered intramuscularly by a healthcare professional, in the anterolateral aspect of the thigh. It should not be injected in the gluteal area or areas where there may be a major nerve trunk and/or blood vessel.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.